ArticleOncoTargets and therapy2015

Heme oxygenase-1 is a predictive biomarker for therapeutic targeting of advanced clear cell renal cell carcinoma treated with sorafenib or sunitinib.

Wan-Xiang Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.